Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study Design to Evaluate the Specificity and Sensitivity of Our Novel System for Detection of Breast and Lung Cancer by Odor Signature

NCT02195076 is registered in ClinicalTrials.gov with BioSense Medical LTD as lead sponsor.

NCT NCT02195076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02195076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study Design to Evaluate the Specificity and Sensitivity of Our Novel System for Detection of Breast and Lung Cancer by Odor Signature
Lead sponsor
BioSense Medical LTD
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2014
Completion date
Not reported
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, lung cancer